Orforglipron is the first oral, non-peptide, small-molecule GLP-1 RA to be approved
Other potential factors Headaches are more common in the general population, so some occurrences may be coincidental or related to other underlying conditions, such as stress, poor sleep, caffeine withdrawal, or migraines
When it expires, it is unclear how beneficiaries will access GLP-1 medications at an affordable price, Stacie Dusetzina, a health policy professor at Vanderbilt University, wrote in a recent article in The New England Journal of Medicine
GLP1 Microdosing Schedule: Doses, Benefits, and Timing Explore how a GLP-1 microdosing schedule works, including weekly vs
I will use it as my maintenance dose over the next two months